ArticleEuropean radiology2026
Opportunistic osteoporosis assessment from routine CT-effect of intravenous contrast agents on absolute values, T-scores, and derived classifications in single- and dual-energy CT.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesComputed tomography (CT) is widely used for bone health assessment, impacting osteoporosis diagnosis and treatment. However, the influence of intravenous contrast agents on CT-based bone mineral density (BMD) measurements remains debated. This study evaluates the effect of contrast agents on Hounsfield measurements, T-scores, and Z-scores, assessing their impact on diagnostic accuracy to reduce misclassification and optimize CT-based BMD assessment. MATERIALS AND
methodsA retrospective analysis of 597 patients (median age: 66 years, 157 females, 440 males) was performed using dual-energy CT (DECT) scans of the abdomen and chest. All patients underwent non-contrast, arterial, and venous phase CT. Automated segmentation (nnU-Net) delineated L1 and L1-L4 trabecular bone, validated by two radiologists. T-scores were calculated according to DEXA-equivalent guidelines.
resultsBased on non-contrast CT, 35% were diagnosed with osteoporosis, 46% with osteopenia, and 18% had normal bone status. Median T-score was -2.0 (L1) and -2.1 (L1-L4) (p < 0.001). Contrast agents significantly altered BMD values, with median changes of 22.9% (arterial) and 20.1% (venous). The most pronounced changes occurred in patients under 50 years (+99% at L1, p < 0.001). In older females, 21% were misclassified as osteopenic instead of osteoporotic (p < 0.001).
conclusionsContrast agents significantly affect BMD measurements, leading to diagnostic misclassification. This effect should be considered when using CT for osteoporosis diagnosis and treatment planning. KEY POINTS: Question Standard CT scans with contrast media may distort bone density measurements, potentially leading to misdiagnosis of osteoporosis and inappropriate clinical decisions. Findings Contrast-enhanced CT scans significantly alter T- and Z-scores, leading to diagnostic shifts in over 50% of patients, especially women over 50. Clinical relevance Our findings highlight the risk of osteoporosis misclassification due to contrast agents in CT imaging, underscoring the need for adjusted interpretation protocols to ensure accurate diagnosis and appropriate treatment, particularly in older adults and female patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.